| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| ALKSAlkermes plc | 4.98B | 30.10 | 21.05 | -5.25% | 16.37% | 13.28% | 0.01% | 0.04 |
| ADMAADMA Biologics, Inc. | 3.71B | 15.57 | 19.22 | 65.15% | 42.87% | 48.57% | 2.97% | 0.24 |
| UTHRUnited Therapeutics Corporation | 21.99B | 503.90 | 18.09 | 10.61% | 41.94% | 18.81% | 4.73% | |
| PCSAProcessa Pharmaceuticals, Inc. | 114.71M | 2.17 | -0.56 | -221.71% | 0.04 | |||
| UNCYUnicycive Therapeutics, Inc. | 144.49M | 6.93 | -1.24 | -100% | -89.15% | 0.10 | ||
| PTHSPelthos Therapeutics Inc. | 85.29M | 26.36 | -1.95 | -318.41% | -40.48% | |||
| MISTMilestone Pharmaceuticals Inc. | 145.64M | 1.71 | -2.55 | -100% | -282.97% | 4.17 | ||
| AMRNAmarin Corporation plc | 5.74B | 13.80 | -3.45 | -25.51% | -38.01% | -18.78% | 0.02 |
Analyze head-to-head performance against top industry competitors across valuation, growth, and profitability metrics.
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 81.76M | 130.08M | 181.1M | 229.21M | 429.75M | 614.06M | 583.19M | 369.19M | 306.91M | 228.61M |
| Revenue Growth % | 50.84% | 59.11% | 39.22% | 26.56% | 87.49% | 42.89% | -5.03% | -36.69% | -16.87% | -25.51% |
| Cost of Goods Sold | 27.88M | 34.36M | 44.95M | 54.54M | 96.02M | 131.44M | 121.33M | 126.71M | 141.37M | 147.23M |
| COGS % of Revenue | 34.1% | 26.42% | 24.82% | 23.8% | 22.34% | 21.41% | 20.8% | 34.32% | 46.06% | 64.4% |
| Gross Profit | 53.88M | 95.72M | 136.15M | 174.67M | 333.74M | 482.62M | 461.86M | 242.48M | 165.54M | 81.38M |
| Gross Margin % | 65.9% | 73.58% | 75.18% | 76.2% | 77.66% | 78.59% | 79.2% | 65.68% | 53.94% | 35.6% |
| Gross Profit Growth % | 59.8% | 77.65% | 42.24% | 28.29% | 91.07% | 44.61% | -4.3% | -47.5% | -31.73% | -50.84% |
| Operating Expenses | 152.1M | 161.35M | 181.71M | 282.9M | 358.01M | 502.27M | 451.36M | 348.35M | 233.13M | 173.18M |
| OpEx % of Revenue | 186.05% | 124.03% | 100.33% | 123.42% | 83.31% | 81.8% | 77.4% | 94.36% | 75.96% | 75.75% |
| Selling, General & Admin | 101.05M | 111.37M | 134.55M | 227M | 323.62M | 463.31M | 408.33M | 304.42M | 199.94M | 152.31M |
| SG&A % of Revenue | 123.6% | 85.62% | 74.29% | 99.03% | 75.3% | 75.45% | 70.02% | 82.45% | 65.15% | 66.62% |
| Research & Development | 51.06M | 49.98M | 47.16M | 55.9M | 34.39M | 38.96M | 29.31M | 30.41M | 22.22M | 20.87M |
| R&D % of Revenue | 62.46% | 38.42% | 26.04% | 24.39% | 8% | 6.34% | 5.03% | 8.24% | 7.24% | 9.13% |
| Other Operating Expenses | -9K | -482K | 74K | -326K | 0 | 104K | 13.72M | 13.53M | 10.97M | 0 |
| Operating Income | -98.22M | -65.63M | -45.55M | -108.22M | -24.28M | -19.66M | 10.5M | -105.87M | -67.59M | -91.8M |
| Operating Margin % | -120.14% | -50.45% | -25.15% | -47.22% | -5.65% | -3.2% | 1.8% | -28.68% | -22.02% | -40.15% |
| Operating Income Growth % | -2.36% | 33.19% | 30.58% | -137.57% | 77.57% | 19.05% | 153.43% | -1108.08% | 36.16% | -35.82% |
| EBITDA | -97.41M | -64.85M | -44.84M | -107.56M | -23.42M | -17.6M | 13.36M | -102.77M | -64.62M | -88.78M |
| EBITDA Margin % | -119.15% | -49.85% | -24.76% | -46.92% | -5.45% | -2.87% | 2.29% | -27.84% | -21.06% | -38.84% |
| EBITDA Growth % | -2.42% | 33.43% | 30.86% | -139.87% | 78.23% | 24.85% | 175.9% | -869.32% | 37.12% | -37.39% |
| D&A (Non-Cash Add-back) | 812K | 777.59K | 715.59K | 667.87K | 859K | 2.05M | 2.86M | 3.1M | 2.96M | 3.01M |
| EBIT | -98.11M | -57.31M | -45.05M | -107.3M | -15.86M | -14.76M | 11.42M | -103.79M | -53.88M | -77.19M |
| Net Interest Income | -20.05M | -18.44M | -9.34M | -7.8M | 1.87M | 2.3M | 1.09M | 2.8M | 11.86M | 13.4M |
| Interest Income | 0 | 234K | 429K | 1.07M | 8.5M | 4.9M | 1.22M | 2.82M | 11.86M | 13.4M |
| Interest Expense | 20.05M | 18.68M | 9.77M | 8.87M | 6.63M | 2.6M | 129K | 15K | 8K | 7K |
| Other Income/Expense | -20.07M | -10.76M | -9.26M | -8.12M | 1.8M | 2.4M | 789K | 2.06M | 13.92M | 14.6M |
| Pretax Income | -118.29M | -76.38M | -55.41M | -116.35M | -22.48M | -17.25M | 11.29M | -103.81M | -53.67M | -77.2M |
| Pretax Margin % | -144.69% | -58.72% | -30.59% | -50.76% | -5.23% | -2.81% | 1.94% | -28.12% | -17.49% | -33.77% |
| Income Tax | -3.09M | 9.97M | 13.05M | 96K | 164K | 745K | 3.56M | 2M | 5.44M | 4.98M |
| Effective Tax Rate % | 97.39% | 113.05% | 122.49% | 100.08% | 100.73% | 104.32% | 68.45% | 101.92% | 110.14% | 106.45% |
| Net Income | -115.2M | -86.35M | -67.86M | -116.44M | -22.64M | -18M | 7.73M | -105.8M | -59.11M | -82.18M |
| Net Margin % | -140.91% | -66.38% | -37.47% | -50.8% | -5.27% | -2.93% | 1.33% | -28.66% | -19.26% | -35.95% |
| Net Income Growth % | -104.39% | 25.05% | 21.41% | -71.58% | 80.55% | 20.51% | 142.94% | -1468.91% | 44.13% | -39.03% |
| Net Income (Continuing) | -115.2M | -86.35M | -68.59M | -116.44M | -22.64M | -18M | 7.73M | -105.8M | -59.11M | -82.18M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -16.60 | -8.20 | -5.00 | -7.80 | -1.32 | -1.00 | 0.38 | -5.20 | -3.00 | -4.00 |
| EPS Growth % | -130.56% | 50.6% | 39.02% | -56% | 83.08% | 24.24% | 138% | -1468.42% | 42.31% | -33.33% |
| EPS (Basic) | -16.60 | -8.20 | -5.00 | -7.80 | -1.32 | -0.94 | 0.39 | -5.20 | -3.00 | -4.00 |
| Diluted Shares Outstanding | 9.03M | 10.59M | 13.53M | 14.86M | 17.13M | 19.09M | 20.12M | 20.06M | 20.38M | 20.55M |
| Basic Shares Outstanding | 8.98M | 10.53M | 13.53M | 14.86M | 17.13M | 18M | 19.8M | 20.06M | 19.7M | 20.55M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 143.52M | 146.33M | 153.27M | 378M | 855M | 879.23M | 878.73M | 689.1M | 724.98M | 595.4M |
| Cash & Short-Term Investments | 106.96M | 98.25M | 73.64M | 249.23M | 644.59M | 500.93M | 454.13M | 309.36M | 320.66M | 294.22M |
| Cash Only | 106.96M | 98.25M | 73.64M | 249.23M | 644.59M | 186.96M | 219.45M | 217.67M | 199.25M | 121.04M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 313.97M | 234.67M | 91.69M | 121.41M | 173.18M |
| Accounts Receivable | 13.83M | 19.98M | 45.32M | 66.52M | 116.43M | 154.57M | 163.65M | 130.99M | 133.56M | 122.28M |
| Days Sales Outstanding | 61.73 | 56.08 | 91.33 | 105.93 | 98.89 | 91.88 | 102.43 | 129.5 | 158.84 | 195.23 |
| Inventory | 18.98M | 20.51M | 30.26M | 57.8M | 76.77M | 188.86M | 234.68M | 228.73M | 258.62M | 166.05M |
| Days Inventory Outstanding | 248.59 | 217.82 | 245.7 | 386.81 | 291.82 | 524.45 | 706 | 658.89 | 667.71 | 411.65 |
| Other Current Assets | 600K | 600K | 600K | 1.5M | 3.91M | 3.92M | 3.92M | 20.02M | 525K | 12.85M |
| Total Non-Current Assets | 29.94M | 20.67M | 8.33M | 7.72M | 27.2M | 86.79M | 189.34M | 197.08M | 106.7M | 89.95M |
| Property, Plant & Equipment | 243K | 78K | 28K | 63K | 10.87M | 10.07M | 9.09M | 9.95M | 8.42M | 7.61M |
| Fixed Asset Turnover | 336.44x | 1667.74x | 6468.00x | 3638.32x | 39.53x | 60.98x | 64.19x | 37.11x | 36.43x | 30.05x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 9.42M | 8.77M | 8.13M | 7.48M | 15.26M | 13.82M | 23.55M | 21.78M | 19.3M | 16.39M |
| Long-Term Investments | 0 | 0 | -1.74M | 0 | 0 | 62.47M | 35M | 1.27M | 0 | 0 |
| Other Non-Current Assets | 2.04M | 741K | 174K | 174K | 1.07M | 432K | 121.71M | 164.08M | 78.97M | 65.95M |
| Total Assets | 173.46M | 167M | 161.6M | 385.71M | 882.21M | 966.02M | 1.07B | 886.18M | 831.68M | 685.35M |
| Asset Turnover | 0.47x | 0.78x | 1.12x | 0.59x | 0.49x | 0.64x | 0.55x | 0.42x | 0.37x | 0.33x |
| Asset Growth % | 1.38% | -3.73% | -3.23% | 138.69% | 128.72% | 9.5% | 10.56% | -17.03% | -6.15% | -17.59% |
| Total Current Liabilities | 50.72M | 76.25M | 108.53M | 157.26M | 242.25M | 307.44M | 370.68M | 259.48M | 259.28M | 179.95M |
| Accounts Payable | 10.83M | 6.06M | 25.16M | 37.63M | 49.95M | 105.88M | 114.92M | 64.6M | 52.76M | 40.37M |
| Days Payables Outstanding | 141.84 | 64.39 | 204.25 | 251.83 | 189.88 | 294 | 345.73 | 186.09 | 136.22 | 100.07 |
| Short-Term Debt | 14.74M | 31.3M | 22.83M | 34.24M | 50.13M | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 923K | 1.17M | 1.64M | 1.22M | 2.34M | 2.93M | 2.65M | 2.2M | 2.34M | 0 |
| Other Current Liabilities | 4.28M | 5.8M | 5.16M | 72M | 16.59M | 28.79M | 45.6M | 35.64M | 185.23M | 139.58M |
| Current Ratio | 2.83x | 1.92x | 1.41x | 2.40x | 3.53x | 2.86x | 2.37x | 2.66x | 2.80x | 3.31x |
| Quick Ratio | 2.46x | 1.65x | 1.13x | 2.04x | 3.21x | 2.25x | 1.74x | 1.77x | 1.80x | 2.39x |
| Cash Conversion Cycle | 168.48 | 209.51 | 132.79 | 240.91 | 200.83 | 322.32 | 462.69 | 602.3 | 690.33 | 506.8 |
| Total Non-Current Liabilities | 251.93M | 99.81M | 118.17M | 76.12M | 31.7M | 31.07M | 30.28M | 31.37M | 20.31M | 19.22M |
| Long-Term Debt | 230.12M | 85.16M | 99.83M | 46.11M | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 9.44M | 9.15M | 8.58M | 10.02M | 8.74M | 7.72M |
| Deferred Tax Liabilities | 8.17M | 0 | 1.74M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 8.51M | 710K | 1.15M | 10.52M | 3.75M | 6.21M | 7.65M | 8.21M | 9.06M | 11.5M |
| Total Liabilities | 302.65M | 176.06M | 226.7M | 233.38M | 273.95M | 338.52M | 400.97M | 290.85M | 279.59M | 199.17M |
| Total Debt | 244.86M | 116.45M | 122.66M | 80.35M | 59.57M | 9.15M | 8.58M | 10.02M | 8.74M | 7.72M |
| Net Debt | 137.9M | 18.2M | 49.02M | -168.88M | -585.01M | -177.81M | -210.88M | -207.65M | -190.51M | -113.31M |
| Debt / Equity | - | - | - | 0.53x | 0.10x | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | 0.64x | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | -15.79x | - | - | - |
| Interest Coverage | -4.90x | -3.51x | -4.66x | -12.20x | -3.66x | -7.55x | 81.41x | -7057.93x | -8448.50x | -13113.86x |
| Total Equity | -129.19M | -9.06M | -65.1M | 152.33M | 608.26M | 627.5M | 667.1M | 595.33M | 552.1M | 486.18M |
| Equity Growth % | -46.06% | 92.99% | -618.7% | 333.99% | 299.31% | 3.16% | 6.31% | -10.76% | -7.26% | -11.94% |
| Book Value per Share | -14.30 | -0.86 | -4.81 | 10.25 | 35.52 | 32.87 | 33.15 | 29.68 | 27.09 | 23.66 |
| Total Shareholders' Equity | -129.19M | -9.06M | -65.1M | 152.33M | 608.26M | 627.5M | 667.1M | 595.33M | 552.1M | 486.18M |
| Common Stock | 149.98M | 207.17M | 208.77M | 246.66M | 269.17M | 290.12M | 294.03M | 299M | 302.76M | 305.3M |
| Retained Earnings | -1.12B | -1.2B | -1.27B | -1.39B | -1.41B | -1.43B | -1.42B | -1.53B | -1.59B | -1.67B |
| Treasury Stock | -411K | -1.51M | -4.23M | -10.41M | -35.9M | -51.08M | -60.73M | -61.77M | -63.75M | -65.33M |
| Accumulated OCI | -754K | 0 | -816K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -84.75M | -71.81M | -32.84M | -94.7M | -9.37M | -21.75M | -66.53M | -179.98M | 6.91M | -31.02M |
| Operating CF Margin % | -103.66% | -55.21% | -18.13% | -41.32% | -2.18% | -3.54% | -11.41% | -48.75% | 2.25% | -13.57% |
| Operating CF Growth % | -17.2% | 15.26% | 54.28% | -188.4% | 90.11% | -132.18% | -205.94% | -170.53% | 103.84% | -549.13% |
| Net Income | -115.2M | -86.35M | -67.86M | -116.44M | -22.64M | -18M | 7.73M | -105.74M | -59.34M | -82.18M |
| Depreciation & Amortization | 812K | 783K | 708K | 669K | 859K | 2.04M | 2.86M | 3.09M | 2.98M | 3.01M |
| Stock-Based Compensation | 13.88M | 13.61M | 13.96M | 18.81M | 30.92M | 45.81M | 0 | 0 | 0 | 17.7M |
| Deferred Taxes | -4.25M | 8.8M | 11.08M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 7.32M | -327K | 2.33M | 2.18M | 1.64M | 2.24M | 38.86M | 26.67M | 12M | -5.73M |
| Working Capital Changes | 12.69M | -8.33M | 6.95M | 84K | -20.14M | -53.83M | -115.98M | -104.01M | 51.27M | 36.17M |
| Change in Receivables | -5.98M | -6.17M | -25.33M | -21.2M | -49.91M | -39.47M | -8.34M | 32.98M | -2.33M | 11.22M |
| Change in Inventory | -5.25M | -1.52M | -9.75M | -27.54M | -18.97M | -112.09M | -167.05M | -36.4M | 56.34M | 105.44M |
| Change in Payables | 10.49M | 8.71M | 40.27M | 37.6M | 65.91M | 114.74M | 51.51M | -102.67M | -164.63K | -77.02M |
| Cash from Investing | -28K | -21K | -12K | -58K | -2.48M | -376.96M | 104.09M | 175.18M | -25.62M | -45.98M |
| Capital Expenditures | -28K | -21K | -12K | -58K | -2.48M | -252K | 0 | -598.63K | -535.07K | 0 |
| CapEx % of Revenue | 0.03% | 0.02% | 0.01% | 0.03% | 0.58% | 0.04% | 0% | 0.16% | 0.17% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 4K | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -28K | -21K | 0 | -58K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 72.2M | 63.13M | 8.23M | 271.25M | 409.61M | -58.91M | -5.07M | -378.77K | 230.89K | -1.44M |
| Debt Issued (Net) | 11.36M | 0 | 11.57M | -14.69M | -31.65M | -50.34M | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1000K | 1000K | -1000K | 1000K | 1000K | 0 | 1000K | 664.59K | 1000K | 131.06K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -194K | 0 | -2.77M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 2.44M | -1.49M | -569K | 21.1M | 1.16M | -8.57M | -9.64M | -1.04M | -1.99M | -1.57M |
| Net Change in Cash | -12.58M | -8.71M | -24.61M | 176.49M | 397.77M | -457.62M | 32.49M | -5.18M | -18.41M | -78.44M |
| Free Cash Flow | -84.78M | -71.84M | -32.85M | -94.76M | -11.84M | -22M | -66.53M | -179.98M | 6.88M | -31.02M |
| FCF Margin % | -103.69% | -55.22% | -18.14% | -41.34% | -2.76% | -3.58% | -11.41% | -48.75% | 2.24% | -13.57% |
| FCF Growth % | -17.24% | 15.26% | 54.27% | -188.47% | 87.5% | -85.73% | -202.43% | -170.53% | 103.82% | -550.7% |
| FCF per Share | -9.39 | -6.78 | -2.43 | -6.38 | -0.69 | -1.15 | -3.31 | -8.97 | 0.34 | -1.51 |
| FCF Conversion (FCF/Net Income) | 0.74x | 0.83x | 0.48x | 0.81x | 0.41x | 1.21x | -8.61x | 1.70x | -0.12x | 0.38x |
| Interest Paid | 12.56M | 17.08M | 17.24M | 21.53M | 4.59M | 2.04M | 0 | 0 | 0 | 0 |
| Taxes Paid | 711K | 1.46M | 1.75M | 850K | 67K | 207K | 0 | 0 | 0 | 3.98M |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | -266.98% | -5.95% | -2.91% | 1.19% | -16.76% | -10.3% | -15.83% |
| Return on Invested Capital (ROIC) | -534.26% | -551.54% | - | - | -543.64% | -6.23% | 1.74% | -18.82% | -13.53% | -18.75% |
| Gross Margin | 65.9% | 73.58% | 75.18% | 76.2% | 77.66% | 78.59% | 79.2% | 65.68% | 53.94% | 35.6% |
| Net Margin | -140.91% | -66.38% | -37.47% | -50.8% | -5.27% | -2.93% | 1.33% | -28.66% | -19.26% | -35.95% |
| Debt / Equity | - | - | - | 0.53x | 0.10x | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x |
| Interest Coverage | -4.90x | -3.51x | -4.66x | -12.20x | -3.66x | -7.55x | 81.41x | -7057.93x | -8448.50x | -13113.86x |
| FCF Conversion | 0.74x | 0.83x | 0.48x | 0.81x | 0.41x | 1.21x | -8.61x | 1.70x | -0.12x | 0.38x |
| Revenue Growth | 50.84% | 59.11% | 39.22% | 26.56% | 87.49% | 42.89% | -5.03% | -36.69% | -16.87% | -25.51% |
Explore detailed financial history, valuation models, and returns analysis
DCF models, peer multiples & analyst estimates
Historical returns with dividends reinvested
Yield, growth, payout safety & DRIP calculator
EPS trends, net income & profitability analysis
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of valuation, profitability & efficiency metrics